Acrx stock forecast.

Based on 7 Wall Street analysts offering 12 month price targets for Applied Digital Corporation in the last 3 months. The average price target is $15.25 with a high forecast of $19.00 and a low forecast of $12.00.

Acrx stock forecast. Things To Know About Acrx stock forecast.

Here are three reasons Aurora Cannabis stock may finally be a buy. Image source: Getty Images. 1. Cost-cutting and restructuring. Aurora Cannabis has been implementing a comprehensive plan to ...From AI system, total return is 2366.52% from 4098 forecasts. See more long term and short term forecasts for your favorite stock.Nov 29, 2023 · Iterum Therapeutics plc (NASDAQ:ITRM) released its quarterly earnings results on Friday, November, 12th. The company reported $0.30 EPS for the quarter, missing the consensus estimate of $1.80 by $1.50. During the same period last year, the company earned ($5.10) EPS. View the latest news, buy/sell ratings, SEC filings and insider transactions ... View the latest AcelRx Pharmaceuticals Inc. (ACRX) stock price, news, historical charts, analyst ratings and financial information from WSJ.

AcelRx Pharmaceuticals, Inc. Common Stock (ACRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

AcelRx Pharmaceuticals (ACRX) Stock Forecast & Price Prediction. Estimation of the future price movement of AcelRx Pharmaceuticals stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions. 1.

Nov 3, 2021 · Cash Ratio forecast for AcelRx Pharmaceuticals (ACRX) stock. Annual Cash Ratio forecast for AcelRx Pharmaceuticals stock for 2021 is 1.08299256789893. It is increase 0.39% from the last annual Cash Ratio report of 1.07883329659834. Annual Cash Ratio forecast for 2022 is 1.07667132533243, and 2023 is 1.07669258943835. ACRX Stock USD 1.76 0.08 4.35% AcelRx Pharmaceuticals stock price prediction is an act of determining the future value of AcelRx Pharmaceuticals shares using few different conventional methods such as EPS estimation , analyst consensus, or …Stock Price Forecast. The 2 analysts offering 12-month price forecasts for AcelRx Pharmaceuticals Inc have a median target of 4.63, with a high estimate of 5.00 and a low estimate of 4.25. The ... The 2 analysts offering 1 year price forecasts for ACRX have a max estimate of — and a min estimate of —. Analyst rating Based on 2 analysts giving stock ratings to ACRX in the past 3 months.

Find real-time OTLK - Outlook Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.

AcelRx Pharmaceuticals last issued its earnings data on November 8th, 2023. The specialty pharmaceutical company reported ($0.08) EPS for the quarter, beating analysts' consensus estimates of ($0.29) by $0.21. The company earned $0.12 million during the quarter. AcelRx Pharmaceuticals has generated ($2.23) earnings per share over the last year ...

Dec 1, 2023 · Vince Angotti. AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. 12 Wall Street analysts have issued 1-year price targets for Arcellx's stock. Their ACLX share price targets range from $39.00 to $104.00. On average, they predict the company's stock price to reach $54.77 in the next twelve months. This suggests a possible upside of 2.8% from the stock's current price.6.51M. ZOMT. 106.30. -1.80%. 108.56M. View the real-time AcelRx (NASDAQ ACRX) share price and assess historical data, charts, technical analysis and the share chat forum.CGEM. Cullinan Oncology, Inc. 8.80. -0.17. -1.90%. In this piece, we will take a look at the twelve cheap healthcare stocks to buy in 2023. For more healthcare stocks, head on over to 5 Cheap ...Find the latest San Juan Basin Royalty Trust (SJT) stock quote, history, news and other vital information to help you with your stock trading and investing.Nov 30, 2023 · Analyst Forecast According to 7 analysts, the average rating for APLD stock is "Strong Buy." The 12-month stock price forecast is $14.21, which is an increase of 204.28% from the latest price.

The image below, which you can click on for greater detail, shows that at December 2021 Achieve Life Sciences had debt of US$14.9m, up from none in one year. However, it does have US$43.0m in cash ...ACRX stock forecast Our latest prediction for Acelrx Pharmaceuticals Inc's stock price was made on the Sept. 14, 2023 when the stock price was at 0.88$ . In the short term (2weeks), ACRX's stock price should underperform the market by -3.79% .The Inpixon stock price gained 1.45% on the last trading day (Wednesday, 29th Nov 2023), rising from $0.0621 to $0.0630. During the last trading day the stock fluctuated 6.05% from a day low at $0.0612 to a day high of $0.0649. The price has fallen in 6 of the last 10 days and is down by -11.89% for this period.1 January 2022 / pennystocks.com / 4 min read Top Penny Stocks To Buy According To Analysts & Targets Up To 615%View the latest AcelRx Pharmaceuticals Inc. (ACRX) stock price, news, historical charts, analyst ratings and financial information from WSJ. Stock Price Forecast The 1 analysts offering 12-month price forecasts for Iterum Therapeutics PLC have a median target of 15.00, with a high estimate of 15.00 and a low estimate of 15.00.

ACRX Analyst Estimates Stock Screener Earnings Calendar Sectors Nasdaq | ACRX U.S.: Nasdaq AcelRx Pharmaceuticals Inc. Watch list NEW Set a price target alert After Hours …Stock Price Forecast. The 3 analysts offering 12-month price forecasts for KALA BIO Inc have a median target of 27.00, with a high estimate of 39.00 and a low estimate of 24.00. The median ...

ACV Auctions Inc. (ACVA) share price prediction for 2023, 2024, 2025, 2026 and 2027. ACVA one year forecast. ACV Auctions stock monthly and weekly forecasts.We are talking returns of at least 300% over the next 12 months, according to the analysts.AcelRx Pharmaceuticals (ACRX)Opioids have made headlines in recent years, and for all the wrong reasons ...From AI system, total return is 2366.52% from 4098 forecasts. See more long term and short term forecasts for your favorite stock.The average twelve-month price prediction for AcelRx Pharmaceuticals is $4.63 with a high price target of $5.00 and a low price target of $4.25. Learn more on ACRX's analyst rating history. Do Wall Street analysts like AcelRx Pharmaceuticals more than its competitors? Analysts like AcelRx Pharmaceuticals more than other Medical companies. Based on 7 Wall Street analysts offering 12 month price targets for Applied Digital Corporation in the last 3 months. The average price target is $15.25 with a high forecast of $19.00 and a low forecast of $12.00. See AcelRx Pharmaceuticals, Inc. (ACRX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Stock Price Forecast. The 2 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 6.65, with a high estimate of 9.50 and a low estimate of 3.80. The ...AcelRx Pharmaceuticals, Inc. 05 Apr, 2023, 08:30 ET. In connection with closing, AcelRx received approximately $2.7 million from Alora Pharmaceuticals and Aguettant. AcelRx announces full ...

See AcelRx Pharmaceuticals, Inc. (ACRX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

The average twelve-month price prediction for AcelRx Pharmaceuticals is $4.63 with a high price target of $5.00 and a low price target of $4.25. Learn more on ACRX's analyst rating history. Do Wall Street analysts like AcelRx Pharmaceuticals more than its competitors? Analysts like AcelRx Pharmaceuticals more than other Medical companies.

5. Next. From AI system, total return is 2366.52% from 4098 forecasts. See more long term and short term forecasts for your favorite stock. Apr 13, 2023 · AcelRx Pharmaceuticals raised capital in December 2022, causing a roughly 50% dilution of existing shareholders on a fully diluted basis. Find out why ACRX stock is a Hold. ACRX stock forecast Our latest prediction for Acelrx Pharmaceuticals Inc's stock price was made on the Sept. 14, 2023 when the stock price was at 0.88$ . In the short term (2weeks), ACRX's stock price should underperform the market by -3.79% .Future criteria checks 1/6. Acerinox is forecast to grow earnings and revenue by 14% and 1.9% per annum respectively. EPS is expected to grow by 14% per annum. Return on equity is forecast to be 11.2% in 3 years.ACRX Business Overview. ACRX is a pharmaceutical company operating in the space of supervised medical settings, i.e. hospitals, ASCs (Ambulatory Surgical Centers), and procedural suites, such as ...14,241.02 -9.83(-0.07%) Russell 2000 1,801.15 -6.35(-0.35%) Crude Oil 75.02 -0.52(-0.69%) Gold 2,014.40 +11.40(+0.57%) Advertisement AcelRx Pharmaceuticals, Inc. (ACRX) …Analyst Forecast. According to 2 analysts, the average rating for ACRX stock is "Strong Buy." The 12-month stock price forecast is $4.63, which is an increase of 571.11% from the latest price.AcelRx Pharmaceuticals, Inc. (ACRX) stock forecast and price target. Find the latest AcelRx Pharmaceuticals, Inc. ACRX analyst stock forecast, price target, and recommendation trends with in-depth ... In today’s fast-paced business environment, accurate forecasting is crucial for making informed decisions and staying ahead of the competition. One powerful tool that can help you achieve this is a forecasting Excel template.Agile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript November 9, 2023 Agile Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-1.58.ACRX competes with other companies such as ATXI, PTIX, and PBLA. On May 9, 2023, ATXI stock remained unchanged, while PTIX stock increased by 2.06%. In contrast, PBLA stock decreased by 21.71%. ACRX is set to report its next earnings on May 11, 2023. ACRX operates in the health technology sector and is involved in the major pharmaceuticals ...

From AI system, total return is 2366.52% from 4098 forecasts. See more long term and short term forecasts for your favorite stock.Stock Price Forecast. The 3 analysts offering 12-month price forecasts for KALA BIO Inc have a median target of 27.00, with a high estimate of 39.00 and a low estimate of 24.00. The median ...AcelRx Pharmaceuticals last issued its earnings data on November 8th, 2023. The specialty pharmaceutical company reported ($0.08) EPS for the quarter, beating analysts' consensus estimates of ($0.29) by $0.21. The company earned $0.12 million during the quarter. AcelRx Pharmaceuticals has generated ($2.23) earnings per share over the last year ...10% most volatile stocks in US Market. 15.5%. 10% least volatile stocks in US Market. 2.9%. Stable Share Price: APLD is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 12% a week. Volatility Over Time: APLD's weekly volatility has decreased from 18% to 12% over the past year, but is still higher than 75% of US ...Instagram:https://instagram. emr nyset rowe dividend growthblackstone insurancevoo stock holdings Nov 29, 2023 · 1 Wall Street research analysts have issued 1-year price objectives for Akari Therapeutics' stock. Their AKTX share price targets range from $30.00 to $30.00. On average, they predict the company's stock price to reach $30.00 in the next year. This suggests a possible upside of 906.7% from the stock's current price. 12.98%. Get the latest AcelRx Pharmaceuticals Inc (ACRX) real-time quote, historical performance, charts, and other financial information to help you make more informed … brookfield infrastructure stockis ninja trader down AcelRx Pharmaceuticals (ACRX) came out with a quarterly loss of $1 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $1.20 per share a year ago. These ...Acelrx Pharmaceuticals (ACRX) stock price prediction is 0.42410325013043 USD. The Acelrx Pharmaceuticals stock forecast is 0.42410325013043 USD for 2024 December 02, Monday with technical analysis. market diary Find real-time NBY - NovaBay Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.May 15, 2023 · Earnings announcement* for ACRX: May 15, 2023. AcelRx Pharmaceuticals, Inc. is estimated to report earnings on 05/15/2023. The upcoming earnings date is derived from an algorithm based on a ... May 9, 2023 · ACRX competes with other companies such as ATXI, PTIX, and PBLA. On May 9, 2023, ATXI stock remained unchanged, while PTIX stock increased by 2.06%. In contrast, PBLA stock decreased by 21.71%. ACRX is set to report its next earnings on May 11, 2023. ACRX operates in the health technology sector and is involved in the major pharmaceuticals ...